ECLEVAR is proud to be selected as part of the UK government's efforts to become a global leader in innovation and high-growth industries.
ECLEVAR is proud to announce that we have been granted the Crédit impôt recherche (CIR), aimed at providing up to a 30% benefit for our clients.
We are thrilled to announce with great pride that ECLEVAR is now part of the "Jeunes Entreprises Innovantes" (Young Innovative Companies)
MEDICAL DEVICE CRO FROM PREMARKET TO POST MARKET CLINICAL FOLLOW-UP (PMCF)
ECLEVAR MEDTECH is a unique CRO, it brings Competent Authority, notified body, industry and CRO expertise together to overcome your clinical evaluation (CER) , clinical trials and regulatory challenges.
The purpose of this document is to guide the medical
We are thrilled to announce our participation as an exhibitor at
We are thrilled to share some exciting news with our
ECLEVAR MEDTECH and Micron Agreed to a Business Alliance in Japan to Provide CRO Services to Medtech Companies
ECLEVAR MEDTECH, a French based CRO specialized in medtech industry,
Introducing MILO: Revolutionizing Healthcare with Personalized, On-Demand Care
MILO is a game-changer in the healthcare industry, providing patients with personalized, on-demand care that is both convenient and effective.
With MILO, patients can receive high-quality medical care without ever leaving their homes, saving time and money while reducing the risk of exposure to illness.
Milo allows you to conveniently and rapidly connect 24/7 with general doctors, nurses, and pharmacists through your device.
BALANCES REGULATORY, CLINICAL EVALUATION, AND BUSINESS RISKS AND OBJECTIVES
Competent authorities around the world exchanges information’s about your products risk and efficacy who put your business on stake. ECLEVAR MEDTECH can see your challenges from different angles for better support and understanding. From clinical reports to clinical data collection.
With an international team that encompass: Former Competent Authority/notified body experts, Clinical Evaluation and PMCF experts from the industry, Medical device CRO experts, Key opinions leader for better understanding of your products
If you want know more, Get In touch with OUR Global Chief commercial OFFICER:
Within 3 years, ECLEVAR delivered transformative solutions.
A Regulators Perspective on Clinical Evaluations and Investigations
- A regulator’s thought on the new clinical evaluation requirements – does it solve the problem?
- What are the key challenges for the regulator in implementing the new requirements?
- The UK – a regulator with ‘two halves’. What are the implications for the UK, and what happens in 2023